Acciones LexaGene Holdings Inc. Toronto S.E.
Acciones
LXG.H
CA52886L1031
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01/03/18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24/03/20 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18/06/18 |
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Tom Slezak
BRD | Director/Board Member | - | 12/10/16 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-27,01 % | 9964,6 M | |
-8,58 % | 3026,19 M | |
+31,86 % | 2999,81 M | |
-13,62 % | 2175,15 M | |
-16,32 % | 1759,83 M | |
+63,36 % | 1421,29 M | |
+27,00 % | 794 M | |
-2,18 % | 756 M | |
+3,18 % | 305 M |